Coronary microembolization: Perfusion-contraction mismatch secondary to myocardial inflammation;Koronare mikroembolisation: Perfusions-kontraktions-mismatch durch inflammatorische reaktion des myokards

Herz

Volumn 29, Issue 8, 2004, Pages 777-781

  Skyschally, Andreas ^a   Schulz, Rainer ^a   Haude, Michael ^a   Erbel, Raimund ^a   Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Coronary microembolization; Inflammation; Microcirculation; Microinfarcts; Plaque rupture

Indexed keywords

ANGINA PECTORIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; HEART ARRHYTHMIA; HEART CONTRACTION; HEART MUSCLE PERFUSION; HUMAN; INFLAMMATION; MICROEMBOLISM; MYOCARDITIS; PROTEIN EXPRESSION; THROMBOSIS;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; EMBOLISM; HUMANS; MICROCIRCULATION; MYOCARDIAL CONTRACTION; VASCULITIS;

EID: 12344334862     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-004-2624-y     Document Type: Article

References (39)

1. Arras M, Strasser R, Mohri M, et al. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 1998;93:97-107.
2. Baker CSB, Dutka DP, Pagano D, et al. Immunocytochemical evidence for inducible nitric oxide synthase and cylooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol 2002;97:409-15.
3. Bonz A, Lengfelder B, Strotmann J, et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pre-treatment with aspirin and clopidogrel (TOPSTAR Trial). J Am Coll Cardiol 2002;40:622-8.
4. Brener SJ, Topol EJ. Troponin, embolization and restoration of microvascular integrity. Eur Heart J 2000;21:1117-9.
5. Burke AP, Tracy R, Virmani R. C-reactive protein as a risk factor for atherothrombosis: a post mortem study. Lab Invest 2001;81:43A. abstract.
6. Coroneos E, Martinez M, McKenna S, et al. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. J Biol Chem 1995;270:23305-9.
7. Cusack MR, Marber MS, Lambiase PD, et al. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002;39:1917-23.
8. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-73.
9. Davies MJ, Thomas AC, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73:418-27.
10. Dörge H, Neumann T, Behrends M, et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000;279:H2587-92.
11. Dörge H, Schulz R, Belosjorow S, et al. Coronary microembolization: the role of TNFα in contractile dysfunction. J Mol Cell Cardiol 2002;34:51-62.
12. El Maraghi N, Genton E. The relevance of platelet and fibrin thrombembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980;62:936-44.
13. Erbel R, Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol 2000;36:22-4.
14. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34.
15. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
16. Frink RJ, Rooney PA, Trowbridge JO, et al. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J 1988;59:196-200.
17. Ge J, Chirillo F, Schwedtmann J, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 1999;81:621-7.
18. Gössl M, Birgelen C von, Mintz GS, et al. Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo. Am J Cardiol 2003;91:992-6.
19. Grund F, Sommerschild HT, Lyberg T, et al. Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance. Am J Physiol Heart Circ Physiol 1999;277:H533-42.
20. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999;340:1623-9.
21. Herrmann J, Haude M, Lerman A, et al. Abnormal coronary flow velocity reserve following coronary intervention is associated with cardiac marker elevation. Circulation 2001;103:2339-45.
22. Herrmann J, Lerman A, Baumgart D, et al. Pre procedural statin medication reduces the extent of peri procedural non-Q-wave myocardial infarction. Circulation 2002;106:2180-3.
23. Herrmann J, Volbracht L, Haude M, et al. Biochemische Marker bei ischämischen und nicht ischämischen Myokardschädigungen. Med Klin 2001;96:144-56.
24. Heusch G, Schulz R. Hibernating myocardium. New answers, still more questions! Circ Res 2002;91:863-5.
25. Heusch G, Schulz R, Erbel R. Inflammatory markers in coronary heart disease: coronary vascular versus myocardial origin? Circulation 2003;108:e4.
26. Hori M, Tamai J, Kitakaze M, et al. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol Heart Circ Physiol 1989;257:H244-51.
27. Kalra DK, Zhu X, Ramchandani MK, et al. Increased myocardial gene expresssion of tumor necrosis factor-α and nitric oxide synthase 2. A potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation 2002;105:1537-40.
28. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol Regul Integ Comp Physiol 1998;274:R577-95.
29. Prati F, Pawlowski T, Gil R, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? Circulation 2003;107:2320-5.
30. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
31. Ritchie ME. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998;98:1707-13.
32. Sabbah HN, Stein PD, Kono T, et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol Heart Circ Physiol 1991;29:H1379-84.
33. Sato H, Iida H, Tanaka A, et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction. J Am Coll Cardiol 2004;44:300-4.
34. Skyschally A, Haude M, Dörge H, et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004;109:2337-42.
35. Skyschally A, Schulz R, Erbel R, et al. Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol 2002;282:H611-4.
36. Thielmann M, Dörge H, Martin C, et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α and sphingosine. Circ Res 2002;90:807-13.
37. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-80.
38. Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMG CoA reductase inhibitors. Basic Res Cardiol 2002;97:105-16.
39. Yokoyama T, Vaca L, Durante W, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993;92:2303-12.